Cost-effectiveness of prophylaxis with palivizumab among high-risk children in Hong Kong: abridged secondary publication

被引：0
|
作者：
Wu, P. [1 ]
Cowling, B. J. [1 ]
Chiu, S. S. [2 ]
Wong, I. O. L. [1 ]
Yeung, W. K. Y. [3 ]
机构：
[1] Univ Hong Kong, Sch Publ Hlth, LKS Fac Med, Hong Kong, Peoples R China
[2] Univ Hong Kong, LKS Fac Med, Dept Paediat & Adolescent Med, Hong Kong, Peoples R China
[3] Pamela Youde Nethersole Eastern Hosp, Dept Paediat & Adolescent Med, Hong Kong, Peoples R China
来源：
HONG KONG MEDICAL JOURNAL | 2023年 / 29卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：37 / 38
页数：2
相关论文
共 50 条
  • [31] Effectiveness and cost-effectiveness of rosuvastatin, atorvastatin, and simvastatin among high-risk patients in usual clinical practice
    Ohsfeldt, Robert L.
    Gandhi, Sanjay K.
    Fox, Kathleen M.
    Stacy, Thomas A.
    McKenney, James M.
    AMERICAN JOURNAL OF MANAGED CARE, 2006, 12 (15): : S412 - S423
  • [32] Efficacy and cost-effectiveness of voriconazole prophylaxis for prevention of invasive aspergillosis in high-risk liver transplant recipients
    Balogh, Julius
    Burroughs, Sherilyn Gordon
    Boktour, Maha
    Patel, Samir
    Saharia, Ashish
    Ochoa, Robert A.
    McFadden, Robert
    Victor, David W.
    Ankoma-Sey, Victor
    Galati, Joseph
    Monsour, Howard P., Jr.
    Fainstein, Victor
    Li, Xian C.
    Grimes, Kevin A.
    Gaber, A. Osama
    Aloia, Thomas
    Ghobrial, R. Mark
    LIVER TRANSPLANTATION, 2016, 22 (02) : 163 - 170
  • [33] Cost-effectiveness of letermovir as cytomegalovirus prophylaxis in adult recipients of allogeneic hematopoietic stem cell transplantation in Hong Kong
    Chan, Thomas Sau-Yan
    Cheng, Sally Shuk-Yee
    Chen, Wei-Ting
    Hsu, Danny Chung
    Chau, Rene Wing-Yan
    Kang, Suk Hyun
    Alsumali, Adnan
    Kwong, Yok-Lam
    JOURNAL OF MEDICAL ECONOMICS, 2020, 23 (12) : 1485 - 1492
  • [34] Cost-effectiveness of bisphosphonate therapy in high-risk osteoporotic women
    Grima, D
    Burge, RT
    Becker, D
    Tosteson, ANA
    OSTEOPOROSIS INTERNATIONAL, 2002, 13 : S82 - S83
  • [35] Cost-effectiveness of antifungal strategies in high-risk neutropenic patients
    Schwarzinger, Michael
    Baillot, Sylvain
    Beauchamp, Celine
    Maury, Sebastien
    Pautas, Cecile
    Vekhoff, Anne
    Farhat, Hassan
    Suarez, Felipe
    Kuentz, Mathieu
    Cordonnier, Catherine
    BLOOD, 2007, 110 (11) : 153B - 153B
  • [36] Cost-Effectiveness of Antifungal Strategies in High-Risk Neutropenic Patients
    Schwarzinger, Michael
    Baillot, Sylvain
    Beauchamp, Celine
    Maury, Sebastien
    Pautas, Cecile
    Vekhoff, Anne
    Farhat, Hassan
    Suarez, Felipe
    Hemery, Francois
    Kuentz, Mathieu
    Cordonnier, Catherine
    BLOOD, 2008, 112 (11) : 475 - 475
  • [37] Safety and cost-effectiveness of MIDCABG in high-risk CABG patients
    Del Rizzo, DF
    Boyd, WD
    Novick, RJ
    McKenzie, FN
    Desai, ND
    Menkis, AH
    ANNALS OF THORACIC SURGERY, 1998, 66 (03): : 1002 - 1007
  • [38] COST-EFFECTIVENESS OF ENVIRONMENTAL SURVEILLANCE IN A HIGH-RISK NEONATAL UNIT
    ELDER, D
    RICHARDSON, H
    CANADIAN JOURNAL OF PUBLIC HEALTH-REVUE CANADIENNE DE SANTE PUBLIQUE, 1977, 68 (04): : 338 - 339
  • [39] Cost-Effectiveness of Treatment Strategies for High-Risk Prostate Cancer
    Kowalchuk, R. O.
    Breen, W.
    Harmsen, W. S.
    Jeans, E.
    Morris, L. K.
    Mullikin, T. C.
    Miller, R. C.
    Wong, W. W.
    Vargas, C. E.
    Trifiletti, D. M.
    Phillips, R.
    Choo, C. R.
    Davis, B. J.
    Pisansky, T. M.
    Tendulkar, R. D.
    Stish, B. J.
    Waddle, M. R.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2021, 111 (03): : E342 - E342
  • [40] COST-EFFECTIVENESS OF TICLOPIDINE IN PREVENTING STROKE IN HIGH-RISK PATIENTS
    OSTER, G
    HUSE, DM
    LACEY, MJ
    EPSTEIN, AM
    STROKE, 1994, 25 (06) : 1149 - 1156
12345